3.2 Diagnostic Biomarkers and Clinical Laboratory Interpretation

Inflammatory Biomarkers: Kinetics and Stewardship Algorithms

Biomarkers provide dynamic, objective biochemical insight into the host inflammatory response to infection. Infectious diseases pharmacists must master biomarker kinetics, pathophysiology, and assay limitations to avoid misinterpreting non-infectious inflammatory elevations.

Procalcitonin (PCT) Pathophysiology and Kinetics

Procalcitonin is a 116-amino acid peptide prohormone of calcitonin:

• Homeostatic Synthesis: In healthy individuals, PCT is synthesized exclusively by thyroid neuroendocrine C-cells and is undetectable in peripheral blood (<0.05 mcg/L).
• Bacterial Infection Induction: In the presence of systemic bacterial infection, lipopolysaccharide (endotoxin) and pro-inflammatory cytokines (interleukin-1beta, tumor necrosis factor-alpha, interleukin-6) induce ubiquitous extrathyroidal PCT expression across all parenchymal tissues (liver, lungs, kidneys, adipose tissue, skeletal muscle).
• Viral Suppression: Conversely, during acute viral infections, immune cells synthesize interferon-gamma (IFN-gamma), which directly blocks and downregulates extrathyroidal PCT transcription. Consequently, viral infections typically produce minimal or absent PCT elevation, making PCT an exceptional discriminator between bacterial and viral lower respiratory tract disease.
• Kinetics: Following an inflammatory stimulus, circulating PCT becomes detectable within 2 to 4 hours, peaks at 12 to 24 hours, and has an elimination half-life of 20 to 24 hours (predominantly cleared via proteolysis with minimal renal clearance).

PCT Clinical Decision Algorithms in Lower Respiratory Tract Infection (LRTI)

In community-acquired pneumonia (CAP), acute exacerbation of chronic bronchitis, and hospital-acquired pneumonia, serial PCT levels guide antimicrobial initiation and cessation:

• <0.10 mcg/L: Bacterial infection highly unlikely. Antimicrobial initiation strongly discouraged.
• 0.10 to 0.24 mcg/L: Bacterial infection unlikely. Antimicrobial initiation discouraged.
• 0.25 to 0.49 mcg/L: Bacterial infection possible. Antimicrobial initiation recommended.
• >=0.50 mcg/L: Bacterial infection highly likely. Antimicrobial initiation strongly recommended.

De-escalation and Discontinuation Algorithm: Repeat PCT every 48 to 72 hours. Antimicrobials can be safely discontinued when:

1. The serum PCT concentration falls to <0.25 mcg/L, OR
2. The serum PCT concentration decreases by >=80% to 90% from the baseline peak level, AND
3. The patient demonstrates clinical improvement (afebrile for >=48 hours, resolving leukocytosis, hemodynamic stability).

Confounding Factors and Limitations of Procalcitonin

C-Reactive Protein (CRP) Pathophysiology and Clinical Utility

C-reactive protein is a 115-kDa pentameric acute-phase reactant synthesized exclusively by hepatocytes under interleukin-6 stimulation:

• Kinetics: Rises significantly slower than PCT. Serum CRP begins rising 12 to 24 hours after an inflammatory trigger, peaks at 48 to 72 hours, and has an elimination half-life of approximately 19 hours.
• Diagnostic Comparison with PCT: CRP is non-specific; it rises dramatically in response to autoimmune flares, surgical incision, venous thromboembolism, and viral infections. Slower kinetics and lack of viral suppression make CRP inferior to PCT for acute antimicrobial initiation and de-escalation in sepsis and pneumonia.
• Therapeutic Monitoring in Deep-Seated Infections: CRP excels as a serial tracking tool for long-term treatment response in slow-clearing, deep-seated infections: osteomyelitis, septic arthritis, prosthetic joint infection (PJI), and infective endocarditis. Normalization or a >=50% decline in CRP validates therapeutic response, confirms source control, and supports safe transition from intravenous to oral antimicrobial therapy.

---

Hematologic Parameters: Complete Blood Count, Left Shift, and Neutrophils

Interpretation of the complete blood count (CBC) with manual differential provides immediate insight into immune competence, infection severity, and bone marrow reserve.

Leukocytosis vs. Leukopenia

• Leukocytosis (WBC >11,000 to 12,000 cells/mcL): Indicates bone marrow granulocyte release driven by granulocyte colony-stimulating factor (G-CSF) and inflammatory cytokines.
• Leukopenia (WBC <4,000 cells/mcL): In the setting of severe sepsis or bacteremia, leukopenia is an ominous prognostic indicator denoting profound peripheral margination of leukocytes, overwhelming bacteremic consumption, or bone marrow exhaustion. Sepsis presenting with leukopenia carries a substantially higher mortality than sepsis presenting with marked leukocytosis.

Immature Granulocytes and the Left Shift

A "left shift" describes the premature release of immature neutrophil precursors from bone marrow storage pools into peripheral circulation:

• Band Forms (>10% of total WBC): The presence of >10% bands (or >20% in some criteria) denotes acute, emergency granulocytopoiesis in response to severe pyogenic stress, even if the total WBC count remains within normal limits. Occult bacteremia is significantly more prevalent in patients with isolated bandemia.
• Metamyelocytes, Myelocytes, and Promyelocytes: Appearance of more primitive precursors reflects severe physiological strain.
• Morphologic Dysplasias: Peripheral blood smear examination revealing toxic granulation (coarse dark primary granules), Dohle bodies (aggregates of rough endoplasmic reticulum), and cytoplasmic vacuolization confirms severe bacterial intoxication.

Absolute Neutrophil Count (ANC) Calculation and Neutropenia Staging

The Absolute Neutrophil Count measures circulating phagocytic defenses:

$\text{ANC (cells/mcL)} = \text{Total WBC (cells/mcL)} \times \frac{\text{Segmented Neutrophils (\%)} + \text{Band Neutrophils (\%)}}{100}$

• Severity Classification:
  • Mild Neutropenia: ANC 1,000 to 1,500 cells/mcL
  • Moderate Neutropenia: ANC 500 to 999 cells/mcL
  • Severe Neutropenia: ANC <500 cells/mcL (or expected to fall <500 cells/mcL within 48 hours)
  • Profound Neutropenia: ANC <100 cells/mcL (drastically elevated risk of invasive mold infections and bacteremia)
• Febrile Neutropenia Definition: Single oral temperature >=38.3°C (101.0°F) or sustained temperature >=38.0°C (100.4°F) for >=1 hour in a patient with severe neutropenia (ANC <500 cells/mcL). This represents a medical emergency requiring broad-spectrum antipseudomonal monotherapy within 1 hour.

---

Cellular Hypoperfusion Markers: Lactate and Base Deficit

Serum lactate and base deficit serve as surrogate biochemical markers of systemic hypoperfusion, tissue hypoxia, and mitochondrial dysfunction in critical infections.

Pathophysiology: Type A vs. Type B Hyperlactatemia

Normal serum lactate is <2.0 mmol/L.

1. Type A Hyperlactatemia (Hypoxic / Hypoperfusion Etiology):

   • Results from an imbalance between cellular oxygen delivery and demand. Anaerobic glycolysis forces pyruvate reduction to lactate via lactate dehydrogenase to regenerate NAD+.
   • Seen in septic shock, cardiogenic collapse, severe hypovolemia, and localized mesenteric ischemia.
   • Sepsis-3 Diagnostic Criterion: Septic shock requires persistent hypotension requiring vasopressors to maintain mean arterial pressure (MAP) >=65 mmHg AND a serum lactate >2.0 mmol/L (>18 mg/dL) despite adequate fluid resuscitation.

2. Type B Hyperlactatemia (Non-Hypoxic / Metabolic Etiology):

   • Occurs without systemic tissue hypoperfusion due to impaired hepatic clearance, altered cellular metabolism, or drug toxicity:
     • Linezolid: Inhibits bacterial 50S ribosomes but cross-inhibits human mitochondrial protein synthesis, inducing mitochondrial respiratory chain failure and lactic acidosis after prolonged exposure (>14 days).
     • Epinephrine / Albuterol: Exogenous epinephrine or endogenous beta-2 adrenergic stimulation accelerates aerobic glycolysis and glycogenolysis via cyclic AMP, elevating lactate despite normal tissue oxygenation.
     • Severe Hepatic Failure: Impairs gluconeogenesis and lactate clearance (the liver clears 70% of circulating lactate).
     • Metformin and Antiretrovirals (NRTIs like stavudine, zidovudine): Impair mitochondrial oxidative phosphorylation.

Lactate Clearance Kinetics in Septic Shock Resuscitation

Serial lactate measurement every 2 to 4 hours during the initial 6 hours of resuscitation provides dynamic prognostic feedback. A lactate clearance rate of >=10% to 20% every 2 hours over the initial 6-hour resuscitation window correlates strongly with microvascular restoration, organ recovery, and reduced in-hospital mortality.

---

Non-Culture Fungal Biomarkers

Fungal blood cultures require days to weeks to grow and exhibit poor sensitivity for invasive molds and deep candidiasis. Non-culture fungal biomarkers enable rapid diagnostic screening and preemptive targeted antifungal initiation.

1. 1,3-beta-D-Glucan (BDG, Fungitell Assay)

1,3-beta-D-glucan is a major cell wall polysaccharide constituent of most fungal pathogens. It is shed into circulation during invasive fungal disease.

• Target Organisms Detected: Pan-fungal marker that detects Candida species (including C. auris), Aspergillus species, Pneumocystis jirovecii, Fusarium, Acremonium, Paecilomyces, and Trichosporon.
• Pathogens NOT Detected (Critical Board Exceptions):
  1. Mucorales (Rhizopus, Mucor, Lichtheimia): Cell walls lack 1,3-beta-D-glucan (composed primarily of chitin and chitosan).
  2. Cryptococcus neoformans / C. gattii: Contains minimal cell wall glucan, and its thick glucuronoxylomannan capsule physically prevents BDG shedding.
  3. Blastomyces dermatitidis: The parasitic yeast phase produces minimal 1,3-beta-D-glucan.
• Interpretation Cutoffs: <60 pg/mL = Negative; 60 to 79 pg/mL = Indeterminate; >=80 pg/mL = Positive. Obtaining two consecutive positive tests significantly enhances diagnostic specificity.
• Causes of False-Positive BDG Results:
  • Hemodialysis utilizing cellulose-based dialyzer membranes.
  • Infusion of human blood fraction products: intravenous immune globulin (IVIG), human serum albumin, or clotting factor concentrates.
  • Surgical gauze, packing sponges, or cellulose wound dressings contacting open peritoneal/pleural cavities during surgery.
  • Cardiopulmonary bypass circuits.
  • Exposure to certain beta-lactam antibiotics (e.g., historical lots of ampicillin-sulbactam, piperacillin-tazobactam).

2. Galactomannan (GM, Platelia Aspergillus EIA)

Galactomannan is a heat-stable exopolysaccharide released from the cell walls of growing Aspergillus hyphae during active tissue angioinvasion.

• Clinical Application: Monitored in serum and bronchoalveolar lavage (BAL) fluid in severely immunocompromised hosts (allogeneic hematopoietic cell transplant recipients and acute leukemia patients with prolonged neutropenia).
• Diagnostic Cutoffs (Optical Density Index - ODI):
  • Serum GM: ODI >=0.5 constitutes a positive result.
  • BAL Fluid GM: ODI >=1.0 for a single test (or >=0.8 if paired with serum >=0.7) constitutes a positive result. BAL GM provides substantially higher diagnostic sensitivity than serum GM in non-neutropenic solid organ transplant recipients (e.g., lung transplant patients) where fungal invasion is localized to pulmonary parenchyma without systemic angioinvasion.
• Cross-Reactivity and False-Positive Triggers:
  • Other fungi sharing galactofuranose epitopes: Histoplasma capsulatum, Blastomyces, Fusarium, Penicillium, and Talaromyces marneffei.
  • Solutions containing sodium gluconate derived from Aspergillus fermentation (e.g., Plasmalyte intravenous hydration fluid).
  • Historical false-positives with piperacillin-tazobactam and ampicillin-sulbactam (largely mitigated by modern manufacturing synthetic pathways, but sporadic cross-reactivity can occur).

3. Cryptococcal Antigen (CrAg)

Cryptococcal antigen testing detects the glucuronoxylomannan (GXM) capsular polysaccharide of Cryptococcus neoformans and Cryptococcus gattii:

• Assay Methodology: Lateral flow assay (LFA) or latex agglutination performed on serum or cerebrospinal fluid (CSF).
• Diagnostic Accuracy: Exceptional performance with sensitivity and specificity exceeding 98% to 99%.
• Screening in Advanced HIV: Routine serum CrAg screening is recommended for all newly diagnosed HIV patients with CD4 counts <100 to 200 cells/mcL to detect subclinical antigenemia prior to antiretroviral therapy (ART) initiation, preventing fatal unmasking immune reconstitution inflammatory syndrome (IRIS).
• Quantitative Titers: Semi-quantitative titer testing provides prognostic staging. A baseline titer >=1:512 correlates with extensive fungal burden, high risk of therapeutic failure, severe intracranial hypertension (elevated CSF opening pressure), and increased IRIS risk.